Cargando…

Glucose- and Non-Glucose-Induced Mitochondrial Dysfunction in Diabetic Kidney Disease

Mitochondrial dysfunction plays an important role in the pathogenesis and progression of diabetic kidney disease (DKD). In this review, we will discuss mitochondrial dysfunction observed in preclinical models of DKD as well as in clinical DKD with a focus on oxidative phosphorylation (OXPHOS), mitoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Marie, Gurumani, Margaret Zvido, Merscher, Sandra, Fornoni, Alessia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945149/ https://www.ncbi.nlm.nih.gov/pubmed/35327540 http://dx.doi.org/10.3390/biom12030351

Ejemplares similares

Mitochondrial Contribution to Inflammation in Diabetic Kidney Disease
por: Mitrofanova, Alla, et al.
Publicado: (2022)

The Vicious Cycle of Renal Lipotoxicity and Mitochondrial Dysfunction
por: Ge, Mengyuan, et al.
Publicado: (2020)

New insights into renal lipid dysmetabolism in diabetic kidney disease
por: Mitrofanova, Alla, et al.
Publicado: (2021)

Implications of Sphingolipid Metabolites in Kidney Diseases
por: Mallela, Shamroop kumar, et al.
Publicado: (2022)

Podocyte Pathology and Nephropathy – Sphingolipids in Glomerular Diseases
por: Merscher, Sandra, et al.
Publicado: (2014)

Use of Lipid-Modifying Agents for the Treatment of Glomerular Diseases
por: Ge, Mengyuan, et al.
Publicado: (2021)

Role of Sphingolipid Signaling in Glomerular Diseases: Focus on DKD and FSGS
por: Mitrofanova, Alla, et al.
Publicado: (2020)

ABCA1 deficiency contributes to podocyte pyroptosis priming via the APE1/IRF1 axis in diabetic kidney disease
por: Ito, Marie, et al.
Publicado: (2023)

Dynamin-mediated Nephrin Phosphorylation Regulates Glucose-stimulated Insulin Release in Pancreatic Beta Cells
por: Jeon, Jongmin, et al.
Publicado: (2012)

Adenine crosses the biomarker bridge: from ‘omics to treatment in diabetic kidney disease
por: Drexler, Yelena, et al.
Publicado: (2023)

High Glucose Induces Mitochondrial Dysfunction in Retinal Müller Cells: Implications for Diabetic Retinopathy
por: Tien, Thomas, et al.
Publicado: (2017)

High-glucose diets induce mitochondrial dysfunction in Caenorhabditis elegans
por: Alcántar-Fernández, Jonathan, et al.
Publicado: (2019)

Maintaining Myocardial Glucose Utilization in Diabetic Cardiomyopathy Accelerates Mitochondrial Dysfunction
por: Wende, Adam R., et al.
Publicado: (2020)

Unraveling the Crosstalk between Lipids and NADPH Oxidases in Diabetic Kidney Disease
por: Njeim, Rachel, et al.
Publicado: (2023)

Cyclodextrin Protects Podocytes in Diabetic Kidney Disease
por: Merscher-Gomez, Sandra, et al.
Publicado: (2013)

High Glucose-Induced Kidney Injury via Activation of Necroptosis in Diabetic Kidney Disease
por: Guo, Man, et al.
Publicado: (2023)

Vildagliptin improves high glucose‐induced endothelial mitochondrial dysfunction via inhibiting mitochondrial fission
por: Liu, Hengdao, et al.
Publicado: (2018)

Safety and efficacy of antihyperglycaemic agents in diabetic kidney disease
por: Niezen, Sebastian, et al.
Publicado: (2019)

Tetramethylpyrazine Ameliorates High Glucose-Induced Endothelial Dysfunction by Increasing Mitochondrial Biogenesis
por: Xu, Qiong, et al.
Publicado: (2014)

Importance of mitochondrial calcium uniporter in high glucose–induced endothelial cell dysfunction
por: Chen, Wei, et al.
Publicado: (2017)

Glucose Transporters in Diabetic Kidney Disease—Friends or Foes?
por: Wasik, Anita A., et al.
Publicado: (2018)

The Effects of Glucose-Lowering Therapies on Diabetic Kidney Disease
por: Agrawal, V., et al.
Publicado: (2015)

The controversial role of glucose in the diabetic kidney
por: Fernandes, Rui
Publicado: (2021)

Sodium-glucose cotransporter 2 inhibitors: extending the indication to non-diabetic kidney disease?
por: Dekkers, Claire C J, et al.
Publicado: (2020)

Complement factor B in high glucose–induced podocyte injury and diabetic kidney disease
por: Lu, Qingmiao, et al.
Publicado: (2021)

Glucose and glycogen in the diabetic kidney: Heroes or villains?
por: Sullivan, Mitchell A., et al.
Publicado: (2019)

Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease
por: Quiroga, Borja, et al.
Publicado: (2022)

Determinants of the Risk of Diabetic Kidney Disease and Diabetic Retinopathy Independent of Glucose Exposure
por: Koo, Bo Kyung
Publicado: (2016)

Chronic kidney disease care delivered by US family medicine and internal medicine trainees: results from an online survey
por: Lenz, Oliver, et al.
Publicado: (2006)

Significance of Endothelial Dysfunction Amelioration for Sodium–Glucose Cotransporter 2 Inhibitor-Induced Improvements in Heart Failure and Chronic Kidney Disease in Diabetic Patients
por: Yanai, Hidekatsu, et al.
Publicado: (2023)

Glucose and Blood Pressure-Dependent Pathways–The Progression of Diabetic Kidney Disease
por: Patel, Devang M., et al.
Publicado: (2020)

Endothelial Toxicity of High Glucose and its by-Products in Diabetic Kidney Disease
por: Dou, Laetitia, et al.
Publicado: (2019)

Evaluation of Serum Glucose and Kidney Disease Progression Among Patients With Diabetes
por: Jung, Hae Hyuk
Publicado: (2021)

Glucose fluctuation promotes mitochondrial dysfunctions in the cardiomyocyte cell line HL-1
por: Mordel, Patrick, et al.
Publicado: (2023)

Sirt6 Suppresses High Glucose-Induced Mitochondrial Dysfunction and Apoptosis in Podocytes through AMPK Activation
por: Fan, Yanqin, et al.
Publicado: (2019)

High glucose and high lipid induced mitochondrial dysfunction in JEG-3 cells through oxidative stress
por: Duan, Yang, et al.
Publicado: (2023)

Sodium glucose transporter‐2 inhibition has no renoprotective effects on non‐diabetic chronic kidney disease
por: Ma, Qiuyue, et al.
Publicado: (2017)

Correction to: Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease
Publicado: (2023)

The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy
por: Østergaard, Leif, et al.
Publicado: (2014)

Cognitive dysfunction in diabetes: abnormal glucose metabolic regulation in the brain
por: Zhang, Shan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nscvfipiicmfjh5g5245kcjrg9